使用符合药品生产质量管理规范（GMP）的物质且无需饲养细胞，从脐带血中扩增具有抗白血病活性的自然杀伤细胞（NK细胞）。 - Suppr

Suppr

超能文献

Expansion of NK cells from cord blood with antileukemic activity using GMP-compliant substances without feeder cells.

作者信息

Tanaka J, Sugita J, Shiratori S, Shigematu A, Asanuma S, Fujimoto K, Nishio M, Kondo T, Imamura M

出版信息

Leukemia. 2012 May;26(5):1149-52. doi: 10.1038/leu.2011.345. Epub 2011 Dec 6.

DOI:10.1038/leu.2011.345

PMID:22143670

Abstract

摘要

相似文献

Expansion of NK cells from cord blood with antileukemic activity using GMP-compliant substances without feeder cells.

Leukemia. 2012 May;26(5):1149-52. doi: 10.1038/leu.2011.345. Epub 2011 Dec 6.

Cytotoxic function of umbilical cord blood natural killer cells: relevance to adoptive immunotherapy.

Pediatr Hematol Oncol. 2011 Nov;28(8):640-6. doi: 10.3109/08880018.2011.613092. Epub 2011 Oct 4.

Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.

Exp Hematol. 2009 Oct;37(10):1216-29. doi: 10.1016/j.exphem.2009.07.009. Epub 2009 Jul 26.

Characterization of cord blood natural killer and lymphokine activated killer lymphocytes following ex vivo cellular engineering.

Biol Blood Marrow Transplant. 2006 Jun;12(6):608-22. doi: 10.1016/j.bbmt.2006.01.009.

Optimized protocols for generation of cord blood-derived cytokine-induced killer/natural killer cells.

Anticancer Res. 2010 Sep;30(9):3493-9.

Production of cytotoxic, KIR-negative NK cells from CD34+ cord blood cells with the use of Notch signaling.

Transfusion. 2011 Nov;51 Suppl 4:145S-152S. doi: 10.1111/j.1537-2995.2011.03377.x.

Natural killer (NK) cells inhibit human umbilical cord blood erythropoiesis.

Exp Hematol. 1995 Oct;23(11):1187-91.

Mode of in vitro augmentation of natural killer cell activity by recombinant human interleukin 2: a comparative study of Leu-11+ and Leu-11- cell populations in cord blood and adult peripheral blood.

J Immunol. 1985 Oct;135(4):2351-6.

[The experimental study on inducing and expanding T/NK cells from mononuclear cells of human umbilical cord blood].

Zhonghua Xue Ye Xue Za Zhi. 2003 Nov;24(11):576-9.

Phenotypic and functional heterogeneity of natural killer cells from umbilical cord blood mononuclear cells.

Immunol Invest. 2008;37(1):79-96. doi: 10.1080/10826080701690714.

引用本文的文献

Building a Better Defense: Expanding and Improving Natural Killer Cells for Adoptive Cell Therapy.

Cells. 2024 Mar 5;13(5):451. doi: 10.3390/cells13050451.

Natural Killer Cells Expanded and Preactivated Exhibit Enhanced Antitumor Activity against Different Tumor Cells in Vitro.

Asian Pac J Cancer Prev. 2020 Jun 1;21(6):1595-1605. doi: 10.31557/APJCP.2020.21.6.1595.

Phase I study of cellular therapy using expanded natural killer cells from autologous peripheral blood mononuclear cells combined with rituximab-containing chemotherapy for relapsed CD20-positive malignant lymphoma patients.

Haematologica. 2020 Apr;105(4):e190-e193. doi: 10.3324/haematol.2019.226696. Epub 2019 Aug 8.

Challenges of NK cell-based immunotherapy in the new era.

Front Med. 2018 Aug;12(4):440-450. doi: 10.1007/s11684-018-0653-9. Epub 2018 Jul 25.

Graft-versus-Leukemia Effect Following Hematopoietic Stem Cell Transplantation for Leukemia.

Front Immunol. 2017 Jun 7;8:496. doi: 10.3389/fimmu.2017.00496. eCollection 2017.

Advances in clinical NK cell studies: Donor selection, manufacturing and quality control.

Oncoimmunology. 2015 Nov 11;5(4):e1115178. doi: 10.1080/2162402X.2015.1115178. eCollection 2016 Apr.

Cellular engineering and therapy in combination with cord blood allografting in pediatric recipients.

Bone Marrow Transplant. 2016 Jan;51(1):27-33. doi: 10.1038/bmt.2015.196. Epub 2015 Sep 14.

Combined IL-15 and IL-12 drives the generation of CD34-derived natural killer cells with superior maturation and alloreactivity potential following adoptive transfer.

Oncoimmunology. 2015 Apr 1;4(7):e1017701. doi: 10.1080/2162402X.2015.1017701. eCollection 2015 Jul.

Revving up Natural Killer Cells and Cytokine-Induced Killer Cells Against Hematological Malignancies.

Front Immunol. 2015 May 13;6:230. doi: 10.3389/fimmu.2015.00230. eCollection 2015.

Improving engraftment and immune reconstitution in umbilical cord blood transplantation.

Front Immunol. 2014 Feb 24;5:68. doi: 10.3389/fimmu.2014.00068. eCollection 2014.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验